Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Beta Bionics, Inc.NASDAQ: BBNX
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities turns positive
Q1 FY2026 other non-current liabilities was $1.56M, compared with -$1 a year earlier. Over 3 fiscal years it compounded at -47.2% a year.
Context
- Other non-current liabilities amounted to 0.5% of total assets at the end of Q1 FY2026, up 0.5 pp from a year earlier.
- Other non-current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +155800000.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 1.55M USD
- Year-over-year change
- -96.6%
- 3-year CAGR
- -47.2%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.55M | -96.6% |
| FY2024 | 2024-12-31 | 44.9M | +18.7% |
| FY2023 | 2023-12-31 | 37.83M | +260.4% |
| FY2022 | 2022-12-31 | 10.5M | — |
Other Non-current Liabilities vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +155800000.0% is the highest of 7, against a peer median of +11.9%.
- Other non-current liabilities amounts to 0.5% of total assets for BBNX, versus a peer median of 2.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 8.52B DKK | -10.0% | +11.9% | 1.4% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $261M USD | — | — | 5.5% |
| Mar 2026 | $206.34M USD | -29.9% | +8.7% | 27.7% | |
| Jun 2026 | $98.5M USD | +3.2% | +23.0% | 1.5% | |
| Jun 2026 | $67.1M USD | +20.5% | — | 2.1% | |
| Mar 2026 | $50.41M USD | +36.0% | +27.6% | 4.4% | |
| Mar 2026 | $1.56M USD | +155800000.0% | -47.2% | 0.5% | |
| Mar 2026 | $238K USD | +621.2% | +56.4% | 0.1% | |
| Peer median (excluding BBNX) | — | +11.9% | +23.0% | 2.1% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.